Corporate ActionJul 31, 2026, 05:21 PM
Veraxa Biotech Registers 19.4M Shares, 6.8M Warrants for Sale
AI Summary
Veraxa Biotech AG filed an F-1 registration statement for the resale of up to 19,436,739 Ordinary Shares underlying warrants and up to 6,786,739 Private Warrants. Additionally, the filing covers up to 120,295,385 Ordinary Shares held by selling securityholders, including those from the recent Business Combination, Cantor Fitzgerald, and High Trail financing. The company also secured a $27.5 million Senior Secured Note from High Trail and entered a purchase agreement with Lincoln Park for up to $50 million in future share sales.
Key Highlights
- Registers up to 19,436,739 Ordinary Shares underlying warrants.
- Registers up to 6,786,739 Private Warrants for sale by securityholders.
- Registers up to 120,295,385 Ordinary Shares for selling securityholders.
- Includes 99,695,385 Ordinary Shares issued to Company Shareholders post-merger.
- Includes 3,500,000 Ordinary Shares issued to Cantor Fitzgerald.
- Includes up to 11,000,000 Ordinary Shares from High Trail Note and Warrant.
- Secured $27.5 million Senior Secured Note and warrant financing from High Trail.
- Entered agreement with Lincoln Park for up to $50 million in share sales.
Price Impact
More from VRXA